The recalled tablets from Vitruvias Therapeutics, Inc. are “superpotent,” the company said, meaning they are stronger than expected ...
CHICAGO--XERIS BIOPHARMA REINFORCES LEADERSHIP IN ENDOCRINOLOGY WITH DATA DISCLOSURES SPANNING COMMERCIAL PORTFOLIO & PIPELINE AT MULTIPLE SCIENTIFIC MEETINGS ...
These four supplements may play a role in thyroid health.
I will write the conclusion first. When people with reduced thyroid function had their test values returned to normal with a ...
A new iScience study integrates East Asian genetic variants with early treatment response data to predict which Graves' ...
Metabolism is often linked with weight, but it does much more than control how quickly the body burns calories. It includes ...
I checked into The Vessyl, a new wellness resort near Costa Rica's Arenal Volcano, to try its 4D sound dome, somatic ...
The day I was diagnosedMarch 2026.I was referred from a fertility clinic to a thyroid specialist and was officially diagnosed with Graves' disease (hyperthyroidism)."If your thyroid levels are not ...
A thyroid medication that was recalled in August because of the possibility of it being "superpotent" has now had its recall elevated to the U.S. Food and Drug Administration's highest risk level.
The Society for Pediatric Research's 2026 Mary Ellen Avery Award recognizes Wendy Chung's work building population-scale newborn screening systems, from spinal muscular atrophy pilots in New ...
Infantile nephropathic cystinosis classically presents with Fanconi syndrome and growth failure, yet atypical acid-base patterns and early endocrine involvement can delay diagnosis. We report a school ...
The FDA has approved tiratricol (Emcitate) to treat peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency, the agency announced last week, marking the first ...